Keywords: hybrigenics, receives, 4m-euro, award, oseo, french, biopharmaceutical
Hybrigenics receives 1.4M-euro award from OSEO
Article | 15 September 2008
Hybrigenics, a French biopharmaceutical company with a focus on cancer treatments, has obtained a 1.4 million-euro ($2.0 million) award from France's national ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- US Supreme Court says patent settlement can "sometimes" be illegal
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
- Additional indications in Japan for Roche's Avastin and Astellas' Prograf
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
